| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Jaundice, Neonatal | D007567 | 7 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Kidney Neoplasms | D007680 | 29 associated lipids |
| Leprosy | D007918 | 8 associated lipids |
| Leukemia P388 | D007941 | 43 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Liver Diseases | D008107 | 31 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tryfinopoulou P et al. | Diversity of Shewanella population in fish Sparus aurata harvested in the Aegean Sea. | 2007 | J. Appl. Microbiol. | pmid:17714405 |
| Hörl WH | Iron therapy for renal anemia: how much needed, how much harmful? | 2007 | Pediatr. Nephrol. | pmid:17206511 |
| Watanabe S et al. | alpha-ketoglutaric semialdehyde dehydrogenase isozymes involved in metabolic pathways of D-glucarate, D-galactarate, and hydroxy-L-proline. Molecular and metabolic convergent evolution. | 2007 | J. Biol. Chem. | pmid:17202142 |
| Vindal V et al. | GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. | 2007 | BMC Genomics | pmid:17714599 |
| Iversen C et al. | The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. | 2007 | BMC Evol. Biol. | pmid:17439656 |
| Breborowicz A et al. | Peritoneal effects of intravenous iron sucrose administration in rats. | 2007 | Transl Res | pmid:17543848 |
| Sav T et al. | Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? | 2007 | Ren Fail | pmid:17497463 |
| Pai AB et al. | Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. | 2007 | Pharmacotherapy | pmid:17316146 |
| Vikrant S | Optimum dosage regimen for iron sucrose. | 2007 | Kidney Int. | pmid:17625585 |
| Reed J et al. | The safety of intravenous iron sucrose use in the elderly patient. | 2007 | Consult Pharm | pmid:17658969 |
| Auerbach M and Rodgers GM | Intravenous iron. | 2007 | N. Engl. J. Med. | pmid:17611217 |
| Agarwal R et al. | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2007 | Kidney Int. | pmid:17622274 |
| Marsillach J et al. | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17324148 |
| George P et al. | Coronary artery vasospasm with iron sucrose. | 2007 | Nephrol. Dial. Transplant. | pmid:17327282 |
| Izuel Rami M et al. | [Budget impact analysis of a blood saving program for urgent traumatological surgery]. | 2007 | Med Clin (Barc) | pmid:17266885 |
| Davey CL et al. | Esterification of select polyols with D-glucaric acid as model reactions for esterification of starch. | 2006 | Carbohydr. Res. | pmid:16973136 |
| Bolger AP et al. | Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. | 2006 | J. Am. Coll. Cardiol. | pmid:16979010 |
| Kato M et al. | Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes. | 2006 | Inorg Chem | pmid:16903719 |
| GarcÃa-Erce JA et al. | Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. | 2006 | Transfus Med | pmid:16999756 |
| Carlini RG et al. | Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro. | 2006 | Nephrol. Dial. Transplant. | pmid:16957011 |
| Agarwal R | Is i.v. iron really superior in CKD patients not on dialysis? | 2006 | Kidney Int. | pmid:16957750 |
| Coletta AP et al. | Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. | 2006 | Eur. J. Heart Fail. | pmid:16887387 |
| Eiselt J et al. | The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. | 2006 | Blood Purif. | pmid:17077626 |
| Sirken G et al. | Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients. | 2006 | Clin. Nephrol. | pmid:17140164 |
| Breborowicz A et al. | Iron sucrose induced morphological and functional changes in the rat kidney. | 2006 | Transl Res | pmid:17145571 |
| Schiesser D et al. | Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. | 2006 | Nephrol. Dial. Transplant. | pmid:16891647 |
| Sudan C et al. | Ubiquitous presence of beta-glucuronidase (GUS) in plants and its regulation in some model plants. | 2006 | Planta | pmid:16652220 |
| Koutroubakis IE et al. | Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. | 2006 | Eur J Gastroenterol Hepatol | pmid:16538115 |
| Guz G et al. | Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients. | 2006 | Nephrol. Dial. Transplant. | pmid:16762960 |
| Barton Pai A et al. | Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose. | 2006 | Am. J. Nephrol. | pmid:16809897 |
| Muñoz M et al. | Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. | 2006 | Transfus Med | pmid:16623920 |
| Bhandal N and Russell R | Intravenous versus oral iron therapy for postpartum anaemia. | 2006 | BJOG | pmid:17004982 |
| Agarwal R | Proinflammatory effects of iron sucrose in chronic kidney disease. | 2006 | Kidney Int. | pmid:16609688 |
| Brown SD et al. | A gold standard set of mechanistically diverse enzyme superfamilies. | 2006 | Genome Biol. | pmid:16507141 |
| Ranfaing E | [Treatments of the martial deficiencies: preparations available in France]. | 2006 | Nephrol. Ther. | pmid:17373280 |
| Singh H et al. | Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. | 2006 | Clin J Am Soc Nephrol | pmid:17699248 |
| Bishu K and Agarwal R | Acute injury with intravenous iron and concerns regarding long-term safety. | 2006 | Clin J Am Soc Nephrol | pmid:17699372 |
| Zager RA | Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. | 2006 | Clin J Am Soc Nephrol | pmid:17699373 |
| Karkouti K et al. | Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. | 2006 | Can J Anaesth | pmid:16371604 |
| Zheng H et al. | Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. | 2006 | Kidney Int. | pmid:16395269 |
| Johnson G et al. | (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. | 2006 | Eur. J. Nucl. Med. Mol. Imaging | pmid:16237571 |
| Cançado RD et al. | [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia]. | 2005 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:16444338 |
| Pecharki GD et al. | Effect of sucrose containing iron (II) on dental biofilm and enamel demineralization in situ. | 2005 Mar-Apr | Caries Res. | pmid:15741724 |
| Al-Mueilo SH | Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. | 2005 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18202490 |
| Zager RA | Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. | 2005 | Kidney Int. | pmid:16164630 |
| Ayotte P et al. | Biomarker measurements in a coastal fish-eating population environmentally exposed to organochlorines. | 2005 | Environ. Health Perspect. | pmid:16203240 |
| Georgopoulos D et al. | Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. | 2005 | Crit Care | pmid:16277712 |
| Spiegel K et al. | Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. | 2005 | J. Appl. Physiol. | pmid:16227462 |
| Aime S et al. | para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents. | 2005 | Org. Biomol. Chem. | pmid:16240012 |
| Schröder O et al. | Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. | 2005 | Am. J. Gastroenterol. | pmid:16279906 |